Long-term changes of blood pressure before cardiovascular mortality: A nested case-control study by 源��쁽李� et al.
ORIGINAL ARTICLE ISSN 1225-8911
Korean Hypertension J 2008;14(1):9-16 ⓒ 2008, The Korean Society of Hypertension
Long-term changes of blood pressure before 
cardiovascular mortality: A nested case-control study
Song Vogue Ahn, Hyeon Chang Kim, Dae Ryong Kang
1
 and Chung Mo Nam, Il Suh
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; 
1
Clinical Trial Center, Yonsei University Health System, Seoul, Korea
ABSTRACT
Background : Although many epidemiologic studies have assessed the association between changes of the blood 
pressure and cardiovascular disease (CVD), any information on the long-term blood pressure change before 
cardiovascular mortality, with performing repeated blood pressure measurements, is limited in Korea. The aim of this 
study was to investigate the association between the long-term changes of the blood pressure and the cardiovascular 
mortality of Korean adults. Methods : We performed a nested case-control study in the Korea Medical Insurance 
Corporation Study cohort. From 1990, we measured the blood pressure and major CVD risk factors every two years 
in 108,461 men and 64,119 women who were aged from 35 to 59 years. The causes and dates of death were obtained 
from the National Statistical Office of Korea. The cases consisted of 1,636 people who died from CVD between 1993 
and 2004 and the controls were 3,272 survivors at the time of sampling. We sampled two controls per case using 
incidence-density sampling and matching for gender and age. Results : The people who died from CVD had higher 
blood pressure than did their controls. These differences were statistically significant from 14 years before death 
(p<0.001 for all examinations). During the 14 years, the systolic blood pressure significantly increased in the people 
who died from CVD (p<0.001) but not in their controls (p=0.811). The annual increase in systolic blood pressure 
among the cases was 0.60 mmHg 0-7 years before death and 0.22 mmHg 8-14 years before death. The diastolic blood 
pressure did not significantly increase in either the cases or in controls. Conclusion : These results support that both 
the long-term blood pressure history and recent increases in blood pressure are associated with the risk of 
cardiovascular mortality. (Korean Hypertension J 2008;14(1):9-16) 
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INTRODUCTION
High blood pressure is the most important, treatable risk 
factor for cardiovascaulr disease (CVD).
1-5)
 Uncontrolled 
hypertension increases the risk of CVD and many clinical 
trials have shown that lowering the blood pressure through 
pharmacological or non-pharmacological intervention can 
decrease these patients’ cardiovascular morbidity and mortality.
6-10)
 
Most epidemiological studies have estimated the relationship 
between a single measurement of blood pressure and the 
development of cardiovascular events. However, 
performing repeated measurements of the risk factors for 
CVD has important advantages in epidemiological studies. 
On the one hand, repeated measurements of the blood 
pressure within short time intervals is likely to provide 
better classification of the individuals by reducing the 
intraindividual variations and the measurement errors of 
the blood pressure.
11,12)
 On the other hand, repeated 
measurements over longer intervals can provide more 
information about the duration of exposure to high blood 
pressure and about the changes of blood pressure. It has 
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been reported that a change of the risk factora is 
associated with changes in the risk of incurring coronary 
heart disease.
13,14)
 The epidemiological data has suggested 
that an individual’s blood pressure history can add 
increments to predicting the future cardiovascular 
morbidity and mortality, yet there is limited information 
on the long-term blood pressure changes, as determined by 
repeated blood pressure measurements, before these 
patients incur cardiovascular mortality.
15,16)
 There have not 
been any Korean studies concerned with the relationship 
of repeated measurements of blood pressure, with 
long-term follow up, and the cardiovascular mortality. The 
aim of this study was to investigate the association 
between the long-term changes of the blood pressure and 
the cardiovascular mortality of Korean adults. 
METHODS
Cohort design and data collection
We performed a nested, case-control study in the Korea 
Medical Insurance Corporation Study cohort and the detailed 
methods of the KMIC Study have been previously 
reported.
17)
 The KMIC provided health insurance to the 
government and private school employees and their 
dependents until 1998, and later it merged with the 
National Health Insurance Corporation. In 1990, the 
corporation insured 1,213,594 workers and 3,389,767 
dependents, which is about 11% of the total Korean 
population. The corporation required all insured employees 
to undergo a biannual physical examination, and 95% and 
94% of the employees completed the examinations in 
1990 and 1992, respectively. The KMIC Study cohort 
consisted of 108,461 men (a 25% random sample) and 
64,119 women (a 100% sample) who were aged from 35 
to 59 years in 1990 and who underwent health examinations. 
Major cardiovascular risk factors, including blood pressure, 
total serum cholesterol, fasting blood glucose and cigarette 
smoking, were repeatedly measured every two years until 
the year 2000. A registered nurse or blood pressure 
technician measured the blood pressures with using a 
standard mercury sphygmomanometer or automatic manometer 
when the subject was seated. If they were using manual 
manometers, they measured the systolic blood pressure 
(SBP) and the diastolic blood pressure (DBP) as the first 
and fifth Korotkoff sounds, respectively. 
Identification of cases and controls
We identified all deaths from January 1, 1993 to 
December 31, 2004 with computerized searches of the 
death certificate data from the National Statistical Office 
for each KMIC cohort member. We classified the causes 
of death according to the International Classification of 
Diseases, 10th revision. The cases included 1,636 people 
who died from disease of the circulatory system (ICD 
codes I00-I99) during the follow-up period. We sampled 
two controls per case with using incidence-density 
sampling. The controls were randomly sampled among the 
cohort members who were alive at the time that their 
matched cases died. The matched variables were gender 
and age, and the age difference between the cases and 
controls was less than six months.
Data analysis
We compared the characteristics noted at the baseline 
examination between the cases and controls with using 
Student’s t-tests and χ2-tests. The subjects’ blood pressure 
could be measured one to six times for each case or 
control because the BP was repeatedly measured in the 
biannual physical examinations from 1990 to 2000. We 
defined an index year for the cases as the calendar year 
when they died and that for the controls as the calendar 
year when their matched cases died. The time of 
measuring the blood pressure was calculated as follows: 
Measuring time = index year – the calendar year of the 
health examination. For each case and control, their blood 
pressure was rearranged according to two-year intervals: 
0-1, 2-3, 4-5, 6-7, 8-9, 10-11, 12-13 and 14 years before 
the index year. The blood pressure levels, according to the 
by different measuring times, were compared between the 
cases and controls using independent t-tests and paired 
t-tests. We calculated an annual increase of the SBP and 
the DBP according to the different periods: less than 7 
years from death (the recent 7 years) and 8 to 14 years 
from death (the remote 7 years). In order to compare the 
blood pressure increases of the cases and controls, we 
performed repeated measurement analyses using Proc 
Mixed in SAS 9.1 (SAS Institute; Cary, NC, USA).
Song Vogue Ahn, et al: Long-term changes of blood pressure before cardiovascular mortality: A nested case-control study 11
Table 1. Baseline Characteristics of the KMIC Cohort
 
Variables Men (n=108,461) Women (n=64,119)
Mean ± SD
  Age (year)
  Body mass index (kg/m2)
  Systolic blood pressure (mmHg)
  Diastolic blood pressure (mmHg)
  Total cholesterol (mg/dL)
  Fasting serum glucose (mg/dL)
45.0 ± 6.7
23.5 ± 2.4
125.5 ± 14.2
82.1 ± 9.6
194.2 ± 33.2
 93.5 ± 21.8
42.5 ± 6.2
22.3 ± 2.5
116.5 ± 12.9
75.7 ± 9.1
189.5 ± 32.7
 86.6 ± 13.7
Number (%)
  Hypertension (≥140/90 mmHg)
  High total cholesterol (≥240 mg/dL)
  High fasting glucose (≥126 mg/dL)
  Cigarette smoking*
     Non-smoker
     Past smoker
     Current smoker
  Alcohol consumption*
     Non-drinker
     <50 g/day
     ≥50 g/day
30,213 (27.9)
9,371 (8.6)
4,960 (4.6)
22,119 (21.2)
22,206 (21.3)
59,966 (57.5)
26,103 (24.8)
69,289 (65.8)
9,900 (9.4)
 6,976 (10.9)
4,598 (7.2)
  833 (1.3)
52,034 (99.1)
  238 (0.5)
  212 (0.4)
50,912 (89.3)
4,939 (8.7)
1,177 (2.1)
*Baseline characteristics are the average of the examinations performed between 1990 and 1992, except for smoking and 
alcohol consumption, which were measured only in 1992.
KMIC: Korea Medical Insurance Corporation.
Table 2. Deaths among the KMIC Cohort, 1993-2004
 
Cause of Death Men Women Total
Cancer
Cardiovascular disease
  Ischemic heart diseases
  Cerebrovascular diseases
  Other cardiovascular diseases
External causes
Digestive tract
Metabolic disorders
Respiratory tract
Infectious diseases
Others
3,366 (44.8)
1,416 (18.8)
  416 (29.4)
  729 (51.5)
  271 (19.1)
1,015 (13.5)
  666 (8.9)
  299 (4.0)
  207 (2.8)
  121 (1.6)
  431 (5.7)
692 (56.0)
220 (17.8)
 48 (21.8)
120 (54.5)
 52 (23.6)
137 (11.1)
 50 (4.1)
 41 (3.3)
 18 (1.5)
 19 (1.5)
 58 (4.7)
4,058 (46.4)
1,636 (18.7)
  464 (28.4)
  849 (51.9)
  323 (19.7)
1,152 (13.2)
  716 (8.2)
  340 (3.9)
  225 (2.6)
  140 (1.6)
  489 (5.6)
Total 7,521 (100) 1,235 (100) 8,756 (100)
KMIC: Korea Medical Insurance Corporation.
RESULTS
Table 1 shows the baseline characteristics of the KMIC 
cohort. The mean age was 45.0 years for the men and 
42.5 years for the women and the mean body mass index 
was 23.5 kg/m
2
 for the men and 22.3 kg/m
2
 for the 
women. The mean SBP was 125.5 mmHg for the men and 
116.5mmHg for the women and the mean DBP was 82.1 
mmHg for the men and 75.7 mmHg for the women. The 
proportion of current smokers was approximately 58% for 
the men and 1% for the women. About 75% of the men 
and 11 % of the women were regular alcohol drinkers.
From 1993 through 2004, 8,756 deaths occurred among 
the KMIC cohort. Cancer was the most common cause of 
death (46.4%) and CVD was the second most common 
cause (18.7%) (Table 2).  
Table 3 shows the characteristics of the cases and 
controls at the baseline examination. The cases and 
controls were matched for gender and age. At the baseline 
examination, the blood pressure and the total serum 
cholesterol and fasting blood glucose levels were higher in 
the cases than in the controls. Current smokers were more 
common in the cases than in the controls. 
Table 4 shows the blood pressure distribution of the 
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Table 3. Characteristics of the Cases and Controls
 
Variables Cases (n=1,636) Controls (n=3,272) p-value
Matched variables
   Gender (male)
   Age at baseline (years)
   Age at death (sampling, years)
1,416 (86.6%)
49.5 ± 6.2
58.9 ± 7.1
2,832 (86.6%)
49.5 ± 6.2
58.9 ± 7.1
1.000
0.987
1.000
Baseline characteristics
   Body mass index (kg/m2)
   Systolic blood pressure (mmHg)
   Diastolic blood pressure (mmHg)
   Total cholesterol (mg/dL)
   Fasting serum glucose (mg/dL)
   Cigarette smoking*
     Non-smoker
     Past smoker
     Current smoker
   Alcohol consumption*
     Non-drinker
     <50 g/day
     ≥50 g/day
23.6 ± 2.6
137.4 ± 20.3
 89.2 ± 13.1
202.3 ± 41.9
102.7 ± 37.1
 385 (25.4%)
 209 (13.8%)
 920 (60.8%)
 541 (34.9%)
 869 (56.1%)
138 (8.9%)
23.5 ± 2.4
127.0 ± 15.7
 82.8 ± 10.2
197.3 ± 33.8
 94.5 ± 22.9
 954 (31.3%)
 651 (21.4%)
1,444 (47.4%)
1,111 (35.5%)
1,797 (57.4%)
 221 (7.1%)
0.053
<.001
<.001
<.001
<.001
<.001
0.081
*Baseline characteristics are the average of the examinations performed between 1990 and 1992 except for smoking and alcohol 
consumption, which were measured only in 1992.
Table 4. Blood Pressure of the Cases and Controls according to the Different Measuring Time Unit: mmHg
 
Measuring Time*
(from case’s death)
Cases Controls Difference (95% CI)†
Systolic blood pressure
   0-1 years
   2-3 years
   4-5 years
   6-7 years
   8-9 years
   10-11 years
   12-13 years
   14 years
144.3 ± 26.4
139.9 ± 23.6
138.4 ± 21.8
138.2 ± 22.2
137.3 ± 21.6
137.7 ± 22.6
136.2 ± 22.9
136.4 ± 21.4
129.5 ± 19.1
127.4 ± 17.7
126.9 ± 17.4
126.9 ± 17.1
127.3 ± 17.0
126.6 ± 16.5
127.2 ± 17.2
127.8 ± 17.1
 16.7 (11.8-21.6)
 12.2 (10.5-14.0)
 11.5 (10.3-12.8)
11.0 (9.7-12.2)
 9.6 (8.4-10.8)
11.1 (9.9-12.4)
 9.0 (7.5-10.4)
 8.5 (6.6-10.5)
Diastolic blood pressure
   0-1 years
   2-3 years
   4-5 years
   6-7 years
   8-9 years
   10-11 years
   12-13 years
   14 years
91.7 ± 16.9
89.5 ± 15.4
88.2 ± 13.8
88.7 ± 13.9
88.8 ± 13.8
89.1 ± 14.6
88.4 ± 15.2
89.3 ± 14.6
83.3 ± 12.4
82.2 ± 11.8
82.5 ± 11.9
82.5 ± 11.6
83.0 ± 11.6
82.6 ± 11.1
83.0 ± 11.7
83.1 ± 11.3
 9.5 (6.5-12.6)
7.4 (6.3-8.5)
6.0 (5.2-6.9)
6.2 (5.4-7.0)
5.7 (4.9-6.5)
6.5 (5.7-7.4)
5.4 (4.4-6.4)
6.2 (4.9-7.5)
*Calendar year of the case’s death- the calendar year of the blood pressure measurement.†
All the differences are statistically significant (p<0.001) on both independent t-tests and paired t-tests.
cases and controls according to the measurement time. The 
SBP and DBP in cases were significantly higher than 
those of the controls for all the measurements on both 
independent t-tests and paired t-tests. Among those cases 
who died from CVD, the mean SBP significantly 
increased from 136.4 mmHg (as measured 14 years before 
death) to 144.3 mmHg (as measured within 2 years from 
death, p<0.001), but among their gender and age-matched 
controls, the mean SBP increased from 127.8 mmHg to 
129.5 mmHg (p=0.811). The diastolic blood pressure did 
not significantly change in either the cases (p=0.811) or in 
their controls (p=0.065).
We analyzed the change of blood pressureof the two 
different periods (the recent 7 years and the remote 7 
years). The SBP of the cases increased by 0.22 mmHg per 
year during the remote 7 years (p=0.260) and by 0.60 
mmHg per year during the recent 7 years (p=0.012). 
However, the SBP of the controls did not increase during 
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Fig. 1. Changes of the blood pressure before cardiovascular 
mortality. 
The data is expressed as means (solid circles) and standard 
errors (vertical lines).
the same periods (p=0.558 and 0.160, respectively). The 
DBP increased only in the cases during the recent 7 years 
(0.30 mmHg per year, p=0.048) (Fig. 1).
DISCUSSION
In this nested case-control study, cardiovascular mortality 
was positively associated with both the past blood pressure 
levels and the recent increases in blood pressure. High 
blood pressure is an important cardiovascular risk factor 
and it has been associated with cardiovascular mortality.
1-5)
 
The previous studies suggested that the past blood pressure 
history was also an independent predictor of the future 
risk for CVD.
15,16)
 In order to divide the effects of the 
absolute level and long-term changes of the blood pressure 
on cardiovascular mortality, the blood pressure should be 
repeatedly measured in cohort studies. With performing 
repeated measurements of blood pressure over 14 years 
and by conducting a nested case-control analysis, we 
compared the absolute level and changes of the blood 
pressure between those cases who died from CVD and 
their age and gender-matched controls. Our results 
suggested that both the long-term blood pressure history 
and a recent increase in blood pressure are associated with 
the risk of cardiovascular mortality.
The previous cohort studies reported that blood pressure 
change was an independent predictor of cardiovascular 
mortality.
18-22)
 Those studies mostly measured the change 
of blood pressure over the first several years and the 
outcome events were observed during the subsequent 
follow-up period. In order to assess the independent 
effects of the change of blood pressure, the previous 
studies controlled for the initial blood pressure level. We 
can expect a positive association between blood pressure 
and cardiovascular mortality with this approach because 
the changes of blood pressure determine the subsequent 
blood pressure, which affects the risk of incurring CVD. 
Other studies have used different approaches that examined 
the previous blood pressure change depending on the final 
attained blood pressure.
23,24)
 The second approach can 
assess the effects of past changes of the blood pressure on 
the cardiovascular mortality at a given level of blood 
pressure. Hofman reported that the increase of blood 
pressure predicts cardiovascular disease depending on the 
initial level of blood pressure, but this didn’t depend on 
the final attained level.
19)
 The Seven Countries Study 
showed that increases in systolic blood pressure during the 
first 10 years of follow up were associated with increased 
cardiovascular and stroke mortality in the subsequent 10 or 
25 years of follow up.
25,26)
 Witteman reported that a 
decline of the diastolic blood pressure indicates stiffening 
of the vessel wall, which is associated with the 
progression of atherosclerosis.
27)
 These various results of 
the previous studies and the  wide range of relative risks 
in relation to incurring CVD may be the result of different 
study populations, outcome measurements and analytic 
approaches. The length of the baseline period, in which 
blood pressure change was measured, varied from 2 to 12 
years and the follow-up period, which varied from 5 to 25 
years, also contributed to the various findings in the 
previous studies.
19,23,25-28)
 Earlier increases of the blood 
pressure can prolong an individual’s exposure to high 
blood pressure. More recent increases in blood pressure 
may accelerate the vascular wall stress.
29)
 According to our 
data, the people who died from CVD experienced 
significant increases of their SBP and DBP while their 
controls did not. This increase was confined to a few 
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years before their deaths. Our data also showed that 
people who died from CVD had significantly higher SBPs 
and DBPs than did their their controls for a long period 
(at least 14 years before death). Our findings support that 
long-term exposure to high blood pressure and a recent 
increase in blood pressure may independently contribute to 
fatal cardiovascular events.
This study has several important strengths. First, the 
blood pressure levels were repeatedly measured for a long 
period before death. The biannual physical examinations 
measured the major cardiovascular risk factors, including 
blood pressure, independently from the outcome events. 
Thus, we could observe the absolute level and long-term 
changes of blood pressure before the cases death from 
CVD. Second, we used a nested case-control analysis 
within a large, established cohort. We had a large number 
of cases and controls that were well matched for their 
gender and age. With this approach, we could compare the 
blood pressure levels between people who died from CVD 
and their gender and age-matched controls. Third, the 
results of our study can be generalized to the Korean 
population as the KMIC Study cohort was recruited from 
across the Korean nation. To assess the generalizability of 
our results to the entire Korean population, we compared 
the characteristics of our subjects with the corresponding 
data from the 1998 Korean National Health and Nutrition 
Examination Survey. The populations were similar for 
several important health indices such as blood pressure, 
total cholesterol, the body mass index, the smoking status 
and alcohol intake.
30,31)
This study also has several potential limitations. First, 
we had no objective information on the medical history of 
the study population. Various health behavior and various 
medications may have contributed to the changes of blood 
pressure, but we could not identify the subjects who were 
taking blood pressure-lowering drugs. Second, the blood 
pressure measurement was not well standardized because 
the health examinations were performed at hundreds of 
hospitals nationwide; thus, the blood pressure levels in this 
study were vulnerable to intraobserver and interobserver 
error. The misclassification bias, if any, is likely to be due 
to non-differential reduction of the association, and so it is 
unlikely the results were distorted by measurement error. 
Finally, cardiovascular mortality is subject to misclassification 
on death certificates. The limitations of the death certificate 
data have been characterized in several previous Korean 
studies.
32,33) 
Chung and colleagues recently assessed the 
accuracy of the registered causes of death in a small 
county in Korea and they reported that the accuracy of 
death certificates was 76.6% for CVD in 1998.
34)
 
However, the accuracy in our study is likely to be much 
higher because the accuracy was higher for the younger, 
well-educated and employed deceased subjects in urban 
areas in Chung’s study.
34)
 The proportion of death 
certificates issued by physicians was also markedly 
increased from 53.9% in 1993 to 77.6% in 2002.
35,36)
In conclusion, those people who die from CVD tend to 
have relatively higher blood pressure at least 14 years 
before death and they experience increases of their blood 
pressure for several years before their death. These findings 
also reaffirm the importance of repeated measurements of 
blood pressure and active blood pressure control to help 
prevent cardiovascular mortality.
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